255 related articles for article (PubMed ID: 21810595)
1. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.
Cabou C; Vachoux C; Campistron G; Drucker DJ; Burcelin R
Diabetes; 2011 Sep; 60(9):2245-56. PubMed ID: 21810595
[TBL] [Abstract][Full Text] [Related]
2. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
[TBL] [Abstract][Full Text] [Related]
3. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
4. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
5. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
6. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Rudd JA
Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
[TBL] [Abstract][Full Text] [Related]
7. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
8. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
9. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Doyle ME; Egan JM
Pharmacol Ther; 2007 Mar; 113(3):546-93. PubMed ID: 17306374
[TBL] [Abstract][Full Text] [Related]
11. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H
Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346
[TBL] [Abstract][Full Text] [Related]
12. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
Sisley S; Smith K; Sandoval DA; Seeley RJ
Peptides; 2014 Aug; 58():1-6. PubMed ID: 24879927
[TBL] [Abstract][Full Text] [Related]
13. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
Rieg T; Gerasimova M; Murray F; Masuda T; Tang T; Rose M; Drucker DJ; Vallon V
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F963-71. PubMed ID: 22832924
[TBL] [Abstract][Full Text] [Related]
15. Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry.
Yang M; Wang J; Wu S; Yuan L; Zhao X; Liu C; Xie J; Jia Y; Lai Y; Zhao AZ; Boden G; Li L; Yang G
Cell Death Dis; 2017 Feb; 8(2):e2609. PubMed ID: 28182013
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]